Merck Serono Opens Drug Development Incubator In Israel

Merck Serono, a division of German pharmaceutical giant Merck, is opening a drug development incubator in Yavne, Israel. The company will invest 10 million euros in the project, supporting the development of Israeli biotech companies. The project is led by Inter-Lab, the R&D center of Merck Serono in Israel, which has already selected a few projects from over 100 applications it received.